Navigation Links
Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation
Date:9/1/2011

STOCKHOLM, September 1, 2011 /PRNewswire/ --

The medical imaging company SyntheticMR AB, a subsidiary to Accelerator Nordic AB, has secured an order for their magnetic resonance imaging software from Umeå University Hospital through their partner Sectra. The software will be used in clinical practice to monitor the treatment efficacy of multiple sclerosis (MS).

The software, SyMRI Diagnostics, includes tools to automatically estimate a measure for brain atrophy and, with minor manual interaction, retrieve the volume of local brain structures and lesions. "SyMRI enables us to retrieve accurate values on the patients status that we could not get before", says Dr Richard Birgander, Neuroradiologist at Umeå University Hospital. "We have analyzed the software's functionality and the results look very good, which has led to a decision to introduce it in regular clinical procedures."

"Magnetic resonance imaging (MRI) generally has been about looking at pictures and trying to interpret them. SyMRI finally provides us with objective numbers," says Dr Anders Svenningsson, Neurologist at Umeå University Hosptial. "My goal is to integrate the SyMRI approach into the Swedish MS register to have more accurate follow-up possibilities for these patients." The Swedish MS register is a nation-wide database that strives to improve care and convey knowledge of Multiple Sclerosis.

The software will be seamlessly integrated in the hospital's radiology IT solutions from Sectra. "Offering third-party clinical innovations like SyMRI Diagnostics tightly integrated in our own IT solutions is an important part of our mission to offer our customers ways to improve their efficiency and the quality of care for their patients," says Dr Torbjörn Kronander, President of Sectra's medical operations.

SyntheticMR has a long standing relationship with Umeå University Hospital, where the SyMRI Diagnostics product has been evaluated on site since 2009 in order to better understand how the software can be used in clinical practice.

Accelerator Nordic AB is a group of Life Science companies focused on pharmaceutical drug development and medical devices. Accelerator's subsidiaries have exposure towards large growth markets such as cancer therapy, medical imaging and orthopedics. The business model is centered on partnering or out-licensing. Accelerator Nordic is publicly traded on the Aktietorget exchange in Stockholm, Sweden. For more information please visit, http://www.acceleratorab.se.

SyntheticMR AB, a subsidiary to Accelerator Nordic AB, has developed SyMRI Diagnostics, software for more effective Magnetic Resonance Imaging. SyMRI Diagnostics uses a rapid MRI scan that provides a measure for patient tissue properties. Using these properties conventional MRI images and tissue images can be generated. In this way examination time is reduced for the patient and the decision support is improved for the radiologist. For more information, please visit http://www.syntheticmr.se.

Sectra develops and sells IT systems and products for radiology, mammography and orthopaedics. More than 1,100 hospitals, clinics and imaging centers worldwide use the systems daily, together performing over 55 million radiology examinations annually. This makes Sectra one of the world- leading companies within systems for handling digital radiology images. In Scandinavia, Sectra is the market leader with more than 50% of all film-free installations. Sectra's systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East. Sectra was founded in 1978 and has its roots in Linköping University in Sweden. The company's business operation includes cutting-edge products and services within the niche segments of medical systems and secure communication systems. Sectra has offices in 12 countries and operates through partners worldwide. Sales in the 2010/2011 fiscal year totaled SEK 911 million. The Sectra share is quoted on the NASDAQ OMX Stockholm AB exchange. For more information, visit http://www.sectra.com.


'/>"/>
SOURCE Accelerator Nordic AB and SyntheticMR AB
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
2. Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
3. Swedish Neuroscience Institute and Institute for Systems Biology in Seattle Form Alliance to Learn More about Brain Diseases
4. University of Houston receives NSF grant for high school teachers program
5. New nanoscale parameter by Aalto University resolves dilemmas on silicon property
6. University of Muenster Bridges 1st Patient to Transplant with SynCardias Total Artificial Heart
7. Elsevier and the National University of Singapore Announce Winners of 24-Hour Hackathon
8. The Human Brain is Sensitive to Light, Breakthrough Findings From Valkee and the University of Oulu
9. CEM President and CEO Delivers Commencement Address at the University of Texas at Austin Chemistry and Biochemistry Department Graduation
10. Computerized system to prevent SIDS developed by Ben-Gurion University students
11. University of Dayton Study Overturns 250-Year-Old Belief About Effects of Age, Repeated Injury on Tissue Regeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- Market Research Future has a half cooked research report on Global ... rapidly and expected to reach USD 450 Million by the end ... ... been assessed as a swiftly growing market and expected that the ... future. There has been a tremendous growth in the prevalence of ...
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research and ... has announced the addition ... - Material, Application - Forecast to 2025" report to ... The report provides a detailed analysis on current ... Market forecasts till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... ANNAPOLIS, Md. and GAITHERSBURG, ... Inc. (NYSE MKT: PIP) and Altimmune, Inc., a ... the signing of a definitive agreement for the ... transaction. Altimmune,s current investors include Novartis Venture Fund, ... company will be a fully-integrated and diversified immunotherapeutics ...
(Date:1/19/2017)... Bethesda, MD (PRWEB) , ... January 18, 2017 ... ... for the National Institutes of Health (NIH) to update its Data Sharing Policy. ... a “scoreable” element of grant applications subject to the existing policy. AMIA recommended ...
Breaking Biology Technology:
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, 2016 ... financial services provider, today announced an agreement with NuData Security, ... to join forces. The partnership will enable clients to focus ... compliance with local data protection regulation. ... In order to provide a ...
(Date:12/15/2016)... HILLS, Mich. , Dec. 15, 2016  There ... unlocking car doors or starting the engine. Continental will ... in Las Vegas . Through the ... (Passive Start and Entry) and biometric elements, the international ... field of vehicle personalization and authentication. "The ...
(Date:12/8/2016)... -- Singulex, Inc., the leader in Next Generation Immunodiagnostics powered ... and supply agreement with Thermo Fisher Scientific, the world ... to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker which, ... diagnose systemic bacterial infection and sepsis and in ... assessing the risk of critically ill patients for progression ...
Breaking Biology News(10 mins):